Artículos de revistas sobre el tema "PMN-MDSCs"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "PMN-MDSCs".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Chen, Li, Li Xiong, Shubing Hong, Jin Li, Zijun Huo, Yudong Li, Shuwei Chen et al. "Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p". Journal of Clinical Endocrinology & Metabolism 105, n.º 8 (3 de junio de 2020): 2704–18. http://dx.doi.org/10.1210/clinem/dgaa344.
Texto completoSprouse, Marc L., Thomas Welte, Debasish Boral, Haowen N. Liu, Wei Yin, Monika Vishnoi, Debalina Goswami-Sewell et al. "PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling". International Journal of Molecular Sciences 20, n.º 8 (18 de abril de 2019): 1916. http://dx.doi.org/10.3390/ijms20081916.
Texto completoTian, Xinyu y Shengjun Wang. "LncRNA AK036396 inhibits maturation and accelerates immunosuppression of polymorphonuclear myeloid-derived suppressor cells by enhancing the stability of ficolin B". Journal of Immunology 204, n.º 1_Supplement (1 de mayo de 2020): 89.4. http://dx.doi.org/10.4049/jimmunol.204.supp.89.4.
Texto completoWang, Shengjun, Xinyu Tian, Tingting Wang, Kai Yin, Dongwei Zhu, Jie Ma y Huaxi Xu. "LncRNA AK036396/FcnB regulating polymorphonuclear myeloid-derived suppressor cells in tumor bearing mice". Journal of Immunology 204, n.º 1_Supplement (1 de mayo de 2020): 164.7. http://dx.doi.org/10.4049/jimmunol.204.supp.164.7.
Texto completoLi, Xing, Xiang-yuan Wu, Nan Jiang, Yan-Fang Xing, Jie Chen y Qu Lin. "Endoplasmic reticulum stress induced Lox-1+ CD15+ polymorphonuclear myeloid-derived suppressor cells in hepatocellular carcinoma and associated with poor prognsis." Journal of Clinical Oncology 36, n.º 5_suppl (10 de febrero de 2018): 38. http://dx.doi.org/10.1200/jco.2018.36.5_suppl.38.
Texto completoChen, Huanhuan, Keqing Yang, Lingxiao Pang, Jing Fei, Yongliang Zhu y Jianwei Zhou. "ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer". Journal for ImmunoTherapy of Cancer 11, n.º 2 (febrero de 2023): e005527. http://dx.doi.org/10.1136/jitc-2022-005527.
Texto completoLi, Xing, Qing-Jian Ye, Yan-Fang Xing, Jin-Xiang Lin, Qu Lin y Xiang-yuan Wu. "Expansion of Lox-1+CD15+ myeloid-derived suppressor cells in hepatocellular carcinoma patients." Journal of Clinical Oncology 35, n.º 7_suppl (1 de marzo de 2017): 124. http://dx.doi.org/10.1200/jco.2017.35.7_suppl.124.
Texto completoLiu, Wangkai, Sitao Li, Yushan Li, Wei Shen, Haitian Chen, Xiaoyu Li, Linnuan Cai et al. "Decreased Polymorphonuclear Myeloid-Derived Suppressor Cells and ROS Production Correlated Closely with Bronchopulmonary Dysplasia in Preterm Infants". Oxidative Medicine and Cellular Longevity 2022 (20 de septiembre de 2022): 1–8. http://dx.doi.org/10.1155/2022/9010354.
Texto completoCheng, Xiang, Hongji Zhang, Allan Tsung y Hai Huang. "Abstract 2544: Preoperative exercise inhibits hepatic metastasis by suppressing PMN-MDSC formation of NETs". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 2544. http://dx.doi.org/10.1158/1538-7445.am2022-2544.
Texto completoBizymi, Nikoleta, Athina Damianaki, Maria Velegraki, Konstantina Zavitsanou, Anastasios Karasachinidis, Anthie Georgopoulou, Irene Mavroudi et al. "Frequency and Functional Analysis of Myeloid-Derived Suppressor Cells (MDSCs) in the Peripheral Blood and Bone Marrow of Patients with Chronic Idiopathic Neutropenia (CIN)". Blood 136, Supplement 1 (5 de noviembre de 2020): 26–27. http://dx.doi.org/10.1182/blood-2020-136500.
Texto completoLi, Congcong, Chao Chen, Xiaomin Kang, Xiaoxin Zhang, Si Sun, Feng Guo, Qiaohong Wang, Xi Kou, Wenxin Bai y Aimin Zhao. "Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils". Human Reproduction 35, n.º 12 (15 de octubre de 2020): 2677–91. http://dx.doi.org/10.1093/humrep/deaa217.
Texto completoMovahedi, Kiavash, Martin Guilliams, Jan Van den Bossche, Rafael Van den Bergh, Conny Gysemans, Alain Beschin, Patrick De Baetselier y Jo A. Van Ginderachter. "Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell–suppressive activity". Blood 111, n.º 8 (15 de abril de 2008): 4233–44. http://dx.doi.org/10.1182/blood-2007-07-099226.
Texto completoYao, G., S. Wang y L. Sun. "THU0226 MESENCHYMAL STEM CELL TRANSPLANTATION AMELIORATES EXPERIMENTAL SJÖGREN’S SYNDROME BY DOWNREGUALTING MDSCS VIA COX2/PGE2 PATHWAY". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 340.1–340. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1391.
Texto completoKim, Rina, Ayumi Hashimoto, Nune Markosyan, Vladimir A. Tyurin, Yulia Y. Tyurina, Shuyu Fu, Mohit Sehgal et al. "Abstract C046: Polymorphonuclear myeloid derived suppressor cells die by ferroptosis in the tumor microenvironment". Cancer Research 82, n.º 22_Supplement (15 de noviembre de 2022): C046. http://dx.doi.org/10.1158/1538-7445.panca22-c046.
Texto completoJensen, Kent P., David A. Hongo, XuHuai Ji, PingPing Zheng, Rahul D. Pawar, Thomas Hsin-Hsu Wu, Stephan Busque et al. "Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipients". Blood Advances 5, n.º 17 (25 de agosto de 2021): 3290–302. http://dx.doi.org/10.1182/bloodadvances.2020003669.
Texto completoGondois-Rey, Françoise, Magali Paul, Florence Alcaraz, Sarah Bourass, Jilliana Monnier, Nausicaa Malissen, Jean-Jacques Grob et al. "Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma". Cancers 13, n.º 6 (17 de marzo de 2021): 1362. http://dx.doi.org/10.3390/cancers13061362.
Texto completoMastio, Jérôme, Thomas Condamine, George Dominguez, Andrew V. Kossenkov, Laxminarasimha Donthireddy, Filippo Veglia, Cindy Lin et al. "Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs". Journal of Experimental Medicine 216, n.º 9 (25 de junio de 2019): 2150–69. http://dx.doi.org/10.1084/jem.20181952.
Texto completoSaito, Masafumi, Yutaka Sugita, Kimihiro Yamashita, Mitsugu Fujita, Kota Yamada, Kyosuke Agawa, Akihiro Watanabe et al. "Abstract 2519: Polymorphonuclear myeloid-derived suppressor cells reflect the status of peritoneal dissemination in colon cancer mouse model". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 2519. http://dx.doi.org/10.1158/1538-7445.am2022-2519.
Texto completoHolokai, Loryn, Jayati Chakrabarti, Joanne Lundy, Daniel Croagh, Pritha Adhikary, Scott S. Richards, Chantal Woodson et al. "Murine- and Human-Derived Autologous Organoid/Immune Cell Co-Cultures as Pre-Clinical Models of Pancreatic Ductal Adenocarcinoma". Cancers 12, n.º 12 (17 de diciembre de 2020): 3816. http://dx.doi.org/10.3390/cancers12123816.
Texto completoOliver, Liliana, Rydell Alvarez, Raquel Diaz, Anet Valdés, Sean H. Colligan, Michael J. Nemeth, Danielle Y. F. Twum et al. "Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator". Journal for ImmunoTherapy of Cancer 10, n.º 9 (septiembre de 2022): e004710. http://dx.doi.org/10.1136/jitc-2022-004710.
Texto completoMoorman, Hannah R., Yazmin Reategui, Dakota B. Poschel y Kebin Liu. "IRF8: Mechanism of Action and Health Implications". Cells 11, n.º 17 (24 de agosto de 2022): 2630. http://dx.doi.org/10.3390/cells11172630.
Texto completoPark, Young-Jun, Boyeong Song, Yun-Sun Kim, Eun-Kyung Kim, Jung-Mi Lee, Ga-Eun Lee, Jae-Ouk Kim, Yeon-Jeong Kim, Woo-Sung Chang y Chang-Yuil Kang. "Myeloid derived suppressor cells(MDSCs) emergence from distinct splenic precursors (162.28)". Journal of Immunology 188, n.º 1_Supplement (1 de mayo de 2012): 162.28. http://dx.doi.org/10.4049/jimmunol.188.supp.162.28.
Texto completoCulpepper, Courtney D., Alexandra V. Tremblay, Zhen Bian, Shuo Niu y Yuan Liu. "IL-17A induced hematopoietic reprogramming produces both PMN and MDSC at the post-acute stage of inflammation." Journal of Immunology 200, n.º 1_Supplement (1 de mayo de 2018): 42.24. http://dx.doi.org/10.4049/jimmunol.200.supp.42.24.
Texto completoFu, Shuyu, Sima Patel, Jerome Mastio, George A. Dominguez, Kevin Alicea Torres, Yulia Nefedova, Jie Zhou y Dmitry I. Gabrilovich. "Dynamics of migration patterns of polymorphonuclear myeloid-derived suppressor cells during tumor progression". Journal of Immunology 202, n.º 1_Supplement (1 de mayo de 2019): 137.4. http://dx.doi.org/10.4049/jimmunol.202.supp.137.4.
Texto completoGuo, Christina, Jan Rekowski, Mateus Crespo, Bora Gurel, Wei Yuan, Adam Sharp, Rafael Grochot et al. "Abstract 3415: The neutrophil-to-lymphocyte ratio (NLR) reflects intratumor myeloid derived suppressor cell (MDSC) infiltration in metastatic castration-resistant prostate cancers (mCRPC)". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 3415. http://dx.doi.org/10.1158/1538-7445.am2022-3415.
Texto completoWu, Sheng-Yan y Chi-Shiun Chiang. "Distinct Role of CD11b+Ly6G−Ly6C− Myeloid-Derived Cells on the Progression of the Primary Tumor and Therapy-Associated Recurrent Brain Tumor". Cells 9, n.º 1 (24 de diciembre de 2019): 51. http://dx.doi.org/10.3390/cells9010051.
Texto completoFallah, Jaleh, C. Marcela Diaz-Montero, Patricia A. Rayman, Wei (Auston) Wei, Iris Yeong Fung Sheng, James Finke, Jin Sub Kim et al. "Correlation of myeloid-derived suppressor cells (MDSC) with pathologic complete response (pCR), recurrence free survival (RFS), and overall survival (OS) in patients with urothelial carcinoma (UC) undergoing cystectomy." Journal of Clinical Oncology 37, n.º 7_suppl (1 de marzo de 2019): 437. http://dx.doi.org/10.1200/jco.2019.37.7_suppl.437.
Texto completoKim, Yun-Sun, Yeon-Jeong Kim, Eun-Kyung Kim, Jung-Mi Lee, Jeong-Hwan Seo, Young-Jun Park, Ho-Woong Kang y Chang-Yuil Kang. "Phenotypical and functional changes in myeloid-derived suppressor cells during the tumor progression: FKBP51 regulates the suppressive function of MDSCs (66.25)". Journal of Immunology 186, n.º 1_Supplement (1 de abril de 2011): 66.25. http://dx.doi.org/10.4049/jimmunol.186.supp.66.25.
Texto completoGiese, Morgan A., Laurel E. Hind y Anna Huttenlocher. "Neutrophil plasticity in the tumor microenvironment". Blood 133, n.º 20 (16 de mayo de 2019): 2159–67. http://dx.doi.org/10.1182/blood-2018-11-844548.
Texto completoRyou, Jeong-Hyun, Gwanghee Lee, Tadatsugu Taniguchi, Hideyuki Yanai y Sho Hangai. "Abstract 242: TCTP is a target for cancer immunotherapy modulating myeloid-derived suppressor cells". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 242. http://dx.doi.org/10.1158/1538-7445.am2022-242.
Texto completoJeong, Seong Mun y Yeon-Jeong Kim. "Astaxanthin Treatment Induces Maturation and Functional Change of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice". Antioxidants 9, n.º 4 (23 de abril de 2020): 350. http://dx.doi.org/10.3390/antiox9040350.
Texto completoTakano, Tomohiro, Takayuki Matsumura, Yu Adachi, Kazutaka Terahara, Saya Moriyama, Taishi Onodera, Ayae Nishiyama et al. "Myeloid cell dynamics correlating with clinical outcomes of severe COVID-19 in Japan". International Immunology 33, n.º 4 (4 de febrero de 2021): 241–47. http://dx.doi.org/10.1093/intimm/dxab005.
Texto completoIto, Atsushi, Yuichi Akama, Naoko Satoh-Takayama, Kanako Saito, Takuma Kato, Eiji Kawamoto, Arong Gaowa, Eun Jeong Park, Motoshi Takao y Motomu Shimaoka. "Possible Metastatic Stage-Dependent ILC2 Activation Induces Differential Functions of MDSCs through IL-13/IL-13Rα1 Signaling during the Progression of Breast Cancer Lung Metastasis". Cancers 14, n.º 13 (4 de julio de 2022): 3267. http://dx.doi.org/10.3390/cancers14133267.
Texto completoAggen, David Henry, Ali Ghasemzadeh, Wendy Mao, Nivi Chowdhury, Matthew Chaimowitz, Jessica Hawley, Vinson Wang et al. "Preclinical development of combination therapy targeting the dominant cytokine interleukin-1β for renal cell carcinoma." Journal of Clinical Oncology 37, n.º 15_suppl (20 de mayo de 2019): e14237-e14237. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e14237.
Texto completoZhou, Jingying, Man Liu, Hanyong Sun, Yu Feng, Liangliang Xu, Anthony W. H. Chan, Joanna H. Tong et al. "Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy". Gut 67, n.º 5 (22 de septiembre de 2017): 931–44. http://dx.doi.org/10.1136/gutjnl-2017-314032.
Texto completoAlcantara, Marice, Dayson Moreira, Chia-Yang Hung, Dongfang Wang, JoAnn Hsu, Sumanta Pal y Marcin Kortylewski. "541 Investigating myeloid derived suppressor cells (MDSCs) and oligonucleotide based targeting of STAT3 in renal cell carcinoma". Journal for ImmunoTherapy of Cancer 8, Suppl 3 (noviembre de 2020): A577. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0541.
Texto completoLi, Tianyu, Xinyu Zhang, Zhuo Lv, Li Gao y Huimin Yan. "Increased Expression of Myeloid-Derived Suppressor Cells in Patients with HBV-Related Hepatocellular Carcinoma". BioMed Research International 2020 (14 de marzo de 2020): 1–8. http://dx.doi.org/10.1155/2020/6527192.
Texto completoKhan, Hamza, Anas Awan, Maria Shishikura, Carley Blevins, Kristen Rodgers, Yuping Mei, Wasay Nizam et al. "Abstract 271: Monitoring of CCR2 and CCR5 expression on circulating myeloid derived suppressor cells (MDSCs) in non-small cell lung cancer as a correlate of minimum residual disease". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 271. http://dx.doi.org/10.1158/1538-7445.am2022-271.
Texto completoAndrés, Celia María Curieses, José Manuel Pérez de la Lastra, Celia Andrés Juan, Francisco J. Plou y Eduardo Pérez-Lebeña. "Myeloid-Derived Suppressor Cells in Cancer and COVID-19 as Associated with Oxidative Stress". Vaccines 11, n.º 2 (19 de enero de 2023): 218. http://dx.doi.org/10.3390/vaccines11020218.
Texto completoBianchi, Anna, Iago De Castro Silva, Nilesh U. Deshpande, Siddharth Mehra, Vanessa T. Garrido, Samara Singh, Christine I. Rafie et al. "Abstract C033: KRAS-TP53 cooperativity regulates Cxcl1 to sustain tumor-permissive circuitry via granulocyte-derived CXCR2-TNF signaling in pancreatic cancer". Cancer Research 82, n.º 22_Supplement (15 de noviembre de 2022): C033. http://dx.doi.org/10.1158/1538-7445.panca22-c033.
Texto completoLu, Xuemin y Xin Lu. "Enhancing immune checkpoint blockade therapy of genitourinary malignancies by co-targeting PMN-MDSCs". Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877, n.º 3 (mayo de 2022): 188702. http://dx.doi.org/10.1016/j.bbcan.2022.188702.
Texto completoRase, Viva Jeanne, James M. Haughian y Nicholas A. Pullen. "The effects of a CRISPR/Cas9 IL-6 knockout in 4T1 mammary carcinoma cells on myeloid-derived suppressor cells (MDSCs) and Th17/Th22 cells". Journal of Immunology 202, n.º 1_Supplement (1 de mayo de 2019): 135.22. http://dx.doi.org/10.4049/jimmunol.202.supp.135.22.
Texto completoTheivanthiran, Balamayooran, Fang Liu, Nicholas DeVito, Michael Plebanek y Brent Hanks. "319 The tumor-intrinsic NLRP3 inflammasome establishes a pulmonary metastatic niche via type II epithelial HSP70/TLR4 signaling and facilitates disease hyperprogression in response to immunotherapy". Journal for ImmunoTherapy of Cancer 9, Suppl 2 (noviembre de 2021): A343. http://dx.doi.org/10.1136/jitc-2021-sitc2021.319.
Texto completoGjerstorff, Morten F., Sofie Traynor, Odd L. Gammelgaard, Simone Johansen, Christina B. Pedersen, Henrik J. Ditzel y Mikkel G. Terp. "PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast Cancer". Cancers 14, n.º 24 (13 de diciembre de 2022): 6153. http://dx.doi.org/10.3390/cancers14246153.
Texto completoGiridharan, Thejaswini, Sora Suzuki, Tiffany R. Emmons, ANM Nazmul Khan, Michael B. Yaffe, Emese Zsiros, Kunle Odunsi, Manmeet Bhalla, Elsa Bou Ghanem y Brahm H. Segal. "Role of the extracellular ATP/adenosine pathway in neutrophil-mediated T cell suppression in ovarian cancer microenvironment". Journal of Immunology 208, n.º 1_Supplement (1 de mayo de 2022): 177.15. http://dx.doi.org/10.4049/jimmunol.208.supp.177.15.
Texto completoLin, Lin, Paul G. Pavicic, Patricia A. Rayman, Charles Tannenbaum, Brian I. Rini, Thomas Hamilton, James Finke y C. Marcela Diaz-Montero. "Accumulation of tumor infiltrating myeloid-derived suppressor cells associates with changes in the immune landscape of clear cell renal cell carcinoma." Journal of Clinical Oncology 36, n.º 6_suppl (20 de febrero de 2018): 655. http://dx.doi.org/10.1200/jco.2018.36.6_suppl.655.
Texto completoMorenkova, A., M. Tikhonova, T. Tyrinova, E. Batorov, A. Sizikov, O. Chumasova, A. Sulutian, V. Koksharova, D. Orlov y E. Chernykh. "AB0059 CLINICAL SIGNIFICANCE OF CIRCULATING MYELOID-DERIVED SUPPRESSOR CELLS IN PATIENTS WITH ANKYLOSING SPONDYLITIS". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 1331.1–1331. http://dx.doi.org/10.1136/annrheumdis-2020-eular.2998.
Texto completoAlghamri, Mahmoud, Ruthvik Avvari, Rohit Thalla, Li Zhang, Maria Ventosa, Ayman Taher, Felipe Núñez et al. "TAMI-52. G-CSF SECRETED BY EPIGENETICALLY REPROGRAMMED MUTANT IDH1 GLIOMA STEM CELLS, REVERSES THE MYELOID CELLS’-MEDIATED IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT". Neuro-Oncology 22, Supplement_2 (noviembre de 2020): ii224. http://dx.doi.org/10.1093/neuonc/noaa215.939.
Texto completoZhou, Xingyu, Deliang Fang, Haohan Liu, Xinde Ou, Chaoyue Zhang, Zirui Zhao, Shaoji Zhao et al. "PMN-MDSCs accumulation induced by CXCL1 promotes CD8+ T cells exhaustion in gastric cancer". Cancer Letters 532 (abril de 2022): 215598. http://dx.doi.org/10.1016/j.canlet.2022.215598.
Texto completoLi, Bao-Hua, Wei Jiang, Shu Zhang, Na Huang, Jin Sun, Jun Yang y Zong-Fang Li. "The spleen contributes to the increase in PMN-MDSCs in orthotopic H22 hepatoma mice". Molecular Immunology 125 (septiembre de 2020): 95–103. http://dx.doi.org/10.1016/j.molimm.2020.07.002.
Texto completo